Celsion Corporation, a clinical stage biotechnology company, focuses on the development and commercialization of DNA-based immunotherapies, vaccines, and directed chemotherapies. Its product pipeline includes GEN-1, a DNA-based immunotherapy for the localized treatment of ovarian cancer; and ThermoDox, a proprietary heat-activated liposomal encapsulation of doxorubicin, which is in development stage for various cancer indications. The company also has two feasibility stage platform technologies for the development of nucleic acid-based immunotherapies, vaccines, and other anti-cancer DNA or RNA therapies. Celsion Corporation was founded in 1982 and is based in Lawrenceville, New Jersey.

NASDAQ:IMNN

Imunon, Inc.

Last Close

1.96

21/09 04:00

Market Cap

14.47M

Beta: 2.08

Volume Today

56.81K

Avg: 57.47K

PE Ratio

−0.05

PFCF: −0.24

People Not Available